NCT06870916

Brief Summary

To develop a new participant educational aid that can be used by participants to support informed decision-making about Multi-Cancer Early Detection (MCED) tests, which are new blood-based screening tests.

Trial Health

53
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial recruitment is currently suspended
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
8mo left

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress64%
Mar 2025Jan 2027

First Submitted

Initial submission to the registry

March 4, 2025

Completed
3 days until next milestone

Study Start

First participant enrolled

March 7, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 11, 2025

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

March 20, 2026

Status Verified

March 1, 2026

Enrollment Period

1.8 years

First QC Date

March 4, 2025

Last Update Submit

March 17, 2026

Conditions

Multi-cancer Early Detection

Outcome Measures

Primary Outcomes (1)

  • Safety and Adverse Events (AEs)

    Through study completion; an average of 1 year.

Study Arms (1)

Multi-cancer Early Detection

Participants will participate in a focus group discussion asking about participants knowledge, preferences, and concerns for MCEDs. During the focus group discussion, investigators will specifically talk about what the tests are and how to decide to get the test as well as their risks and benefits.

Other: Multi-cancer Early Detection

Interventions

Multi-cancer Early DetectionOTHER

Participants will participate in a focus group discussion asking about your knowledge, preferences, and concerns for MCEDs. During the focus group discussion, investigators will specifically talk about what the tests are and how to decide to get the test as well as their risks and benefits.

Multi-cancer Early Detection

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

MD Anderson Cancer Center

You may qualify if:

  • Recruitment and eligibility will be assessed by CCETR.CCETR staff will help distribute recruitment flyers, assess subject eligibility, and refer eligible subjects to the research team (Appendix B, C \& I).

You may not qualify if:

  • History of cancer other than basil cell and squamous cell skin cancer, per self-report.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

Study Officials

  • Robert Volk, PHD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 4, 2025

First Posted

March 11, 2025

Study Start

March 7, 2025

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2027

Last Updated

March 20, 2026

Record last verified: 2026-03

Locations

US(1)